Methyl ethyl(2-(3-methoxyphenyl)benzo[d]oxazol-5-yl)phosphinate

ID: ALA4762738

PubChem CID: 162660448

Max Phase: Preclinical

Molecular Formula: C17H18NO4P

Molecular Weight: 331.31

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCP(=O)(OC)c1ccc2oc(-c3cccc(OC)c3)nc2c1

Standard InChI:  InChI=1S/C17H18NO4P/c1-4-23(19,21-3)14-8-9-16-15(11-14)18-17(22-16)12-6-5-7-13(10-12)20-2/h5-11H,4H2,1-3H3

Standard InChI Key:  FDJVGIRRTPMYQG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   12.7352   -8.3741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7341   -9.1936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4421   -9.6026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4403   -7.9652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1489   -8.3705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1537   -9.1891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9338   -9.4376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4111   -8.7724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9260   -8.1131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0260   -9.6017    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   11.3186   -9.1925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0254  -10.4189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3174  -10.8269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6004  -10.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3878  -10.9668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2263   -8.7671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6385   -9.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4549   -9.4696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8601   -8.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4430   -8.0513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6279   -8.0593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8449   -7.3398    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6620   -7.3321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  2 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 10 14  1  0
 14 15  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  8 16  1  0
 20 22  1  0
 22 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4762738

    ---

Associated Targets(Human)

UTRN Tchem Utrophin (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 331.31Molecular Weight (Monoisotopic): 331.0973AlogP: 4.07#Rotatable Bonds: 5
Polar Surface Area: 61.56Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.66Np Likeness Score: -0.90

References

1. Chatzopoulou M,Emer E,Lecci C,Rowley JA,Casagrande AS,Moir L,Squire SE,Davies SG,Harriman S,Wynne GM,Wilson FX,Davies KE,Russell AJ.  (2020)  Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.,  11  (12): [PMID:33335663] [10.1021/acsmedchemlett.0c00405]
2. Chatzopoulou, Maria and 16 more authors.  2020-03-12  Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid.  [PMID:31599580]
3. Babbs, Arran and 19 more authors.  2020-07-23  2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.  [PMID:32551645]
4. Chatzopoulou, Maria and 12 more authors.  2020-12-10  Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.  [PMID:33335663]

Source